Immune mediated inflammatory diseases are a group of disorders which may sound and look very different but share an important commonality — inflammation. Immune mediated inflammatory diseases consist of more than 80 chronic autoimmune diseases targeting virtually any part of the body, including:
Diseases as varied as rheumatoid arthritis, multiple sclerosis, asthma, psoriasis, ulcerative colitis, and Crohn's disease are among those classified as immune mediated inflammatory diseases.
The Infusion Center at Magee is one of the only dedicated treatment centers in the region for immune mediated inflammatory diseases. The center is supported by the University of Pittsburgh School of Medicine, which is among 19 academic institutions on the Federation of Clinical Immunology Societies (FOCIS) Academic Platform, assembled to work collaboratively to study the diagnosis and treatment of immune disorders.
The center is dedicated to state-of-the-art infusion therapy for two immune mediated inflammatory diseases — Crohn's disease and rheumatoid arthritis — in an atmosphere focused on inflammatory diseases.
At the center, professionals work closely with physicians from gastroenterology and rheumatology practices, along with primary care physicians from throughout the region, to meet the needs of these patients. The center's experts are always ready to apply research advances as biotherapeutics are approved to treat these and other conditions.
Doctors and patients can find the team of specialists needed to treat all aspects of these challenging disorders within one center, saving significant time in both the treatment and the healing process.